Clinical trial for early-stage non-small cell lung cancer

Below is information on the INTerpath 009 study which is a clinical trial for early-stage non-small cell lung cancer (NSCLC). This clinical trial is trying to determine if an investigational study drug combination, when given after initial treatment and surgery, may work to help keep NSCLC from coming back or going to other areas of the body. For more information on this, or other clinical trials, please contact:  Dr. Susan Johnson, Director of Research sjohnson@echoct.com / 860-886-8362. 

For more information on this, or other clinical trials, please contact:  Dr. Susan Johnson, Director of Research sjohnson@echoct.com / 860-886-8362.